BiferaRx™ is a prescription iron supplement. BiferaRx™ is a small oval, film-coated maroon tablet, with black core, debossed and bisected with "AP|85" on one side, and plain on the other.
Each BiferaRx™ tablet contains:
Amount per serving:
Folic Acid 1 mg
B12 (as cyanocobalamin) 25 mcg
as PIC (polysaccharide iron
complex) 22 mg
as HIP (heme iron polypeptide as Proferrin - bovine source, USDA certified) 6 mg
Microcrystalline cellulose, croscarmellose sodium, crospovidone, magnesium stearate, silicon
dioxide, coating (polyvinyl alcohol, polyethylene glycol, talc, FD&C red no. 40 aluminum lake, titanium
dioxide, FD&C blue no. 2 aluminum lake).
BiferaRx™ is a prescription iron supplement indicated for use in improving the nutritional status of iron deficiency.
DOSAGE AND ADMINISTRATION
One tablet daily with or without food or as prescribed by a licensed healthcare provider with prescribing authority.
BiferaRx™ tablets are supplied in child-resistant bottles of 90 tablets (NDC 68220-085-90) and as a Professional Sample 5 tablet blister pack (NDC 68220-085-25).
KEEP OUT OF REACH OF CHILDREN.
Store at controlled room temperature 20°-25°C (68°-77°F). Excursions permitted to 15°-30°C (59°- 86°F). [See current USP]
Dispense in a tight, light-resistant container to protect from light and moisture.
For medical inquiries call toll free 1-888-317-0001. www.BiferaRx.com. Manufactured for: ALAVEN PHARMACEUTICAL LLC, Marietta, GA 30062.Revised: Mar 2010
Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
No information provided.
Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6.
Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.
Folic acid when administered as a single agent in doses above 0.1mg daily may obscure pernicious anemia in that hematological remission can occur while neurological manifestations remain progressive. While prescribing this nutritional supplement for pregnant women, nursing mothers, or for women prior to conception, their medical condition and other drugs, herbs, and/or supplements consumption should be considered.
No information provided.
This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.
Hemochromatosis and hemosiderosis are contraindications to iron therapy.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.